Management Team

Jean Chalopin is an experienced creative entrepreneur and businessman.
As the Executive Chairman of Deltec International Group, a long-standing private bank, he has been instrumental to the negotiation, management, operation and successful exits of various funds and companies, especially in the biotechnology sector, in the US, Europe, Japan and China.

Ye Tian is a seasoned investor in pharmaceutical companies and General Partner of Fortified Investment.

Mr. Tian has also invested into and served on the board of several fast-growing high-tech companies. He has degrees in mathematics and economics from Harvard University, USA.

After working as a researcher in the field of vaccines and immunotherapy, Christian Bréchot was president and general manager of the largest scientific institutions in the field of health in France.
Dr. Brechot is currently the Senior Associate Dean for Research in Global Affairs and the Associate Vice-President for International Partnerships and Innovation at the University of South Florida, Tampa, USA.
Additionally, he is currently the President of the Global Virus Network, Baltimore, USA and was the former President of the Institut Pasteur, Paris, France.

Co-founder and Head of the preclical development at Vaxon Biotech, she led research and development projects for more than 20 years. She has extensive experience in tumour immunology and anti-tumour vaccination. Her in-depth knowledge covers the entire process, from experimental developments to clinical trials. She is an expert in moving experimental cancer vaccines into Phase I and II clinical trials. Jeanne Menez-Jamet has a university degree in microorganism genetics and a post doctoral experience at the Institut Gustave Roussy.

Estelle Besson has a Masters in Cellular and Molecular Biology and more than 20 years of progressive experience in Clinical Research from operational to management positions.
She successfully delivered several large international clinical trials, demonstrated team leadership and people management. Familiar with ICH-GCP, the regulations and all actors of the clinical research she leverages her expertise to bring the scientific discoveries into Clinical Operations.